Advisory Council on Alzheimer's Research, Care, and Services; Meeting, 80575 [2024-22763]
Download as PDF
Federal Register / Vol. 89, No. 192 / Thursday, October 3, 2024 / Notices
charter gives the PACCARB
authorization to operate until August
29, 2026.
A copy of the charter is available on
the PACCARB’s website at:
www.hhs.gov/paccarb.
Dated: September 26, 2024.
B. Kaye Hayes,
Director, Office of Infectious Disease and HIV/
AIDS Policy, Office of the Assistant Secretary
for Health.
[FR Doc. 2024–22794 Filed 10–2–24; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Council on Alzheimer’s
Research, Care, and Services; Meeting
Assistant Secretary for
Planning and Evaluation, HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces the
public meeting of the Advisory Council
on Alzheimer’s Research, Care, and
Services (Advisory Council). The
Advisory Council provides advice on
how to prevent or reduce the burden of
Alzheimer’s disease and related
dementias on people with the disease
and their caregivers. During the
meeting, the Advisory Council will hear
updates from federal agencies on
activities during the last quarter and
from panels organized by the clinical
care and risk reduction subcommittees.
Presenters will discuss dementia care
from different perspectives, including
those of providers, people with lived
experience, and CMMI GUIDE Model
participants, as well as how to bridge
gaps in service delivery.
DATES: The meeting will be October 21,
2024, from 9:30 a.m. to 4:30 p.m.
ADDRESSES: The meeting will be a
hybrid of in-person and virtual. The
meeting will be held in Room 800 of the
Hubert H. Humphrey Building, 200
Independence Avenue SW, Washington,
DC 20201. It will also stream live at
www.hhs.gov/live.
Comments: Time is allocated on the
agenda to hear public comments from
4:00 p.m. to 4:25 p.m. on Monday,
October 21. The time for oral comments
will be limited to two (2) minutes per
individual. To provide a public
comment, please register by emailing
your name to napa@hhs.gov by
Wednesday, October 16. Registered
commenters will receive both a dial-in
number and a link to join the meeting
virtually; individuals will have the
choice to either join virtually via the
link, or to call in only by using the dialin number. Note: There may be a 30–45
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:59 Oct 02, 2024
Jkt 265001
second delay in the livestream video
presentation of the conference. For this
reason, if you have pre-registered to
submit a public comment, it is
important to connect to the meeting by
3:45 p.m. to ensure that you do not miss
your name and allotted time when
called. If you miss your name and
allotted time to speak, you may not be
able to make your public comment.
Public commenters will not be admitted
to the virtual meeting before 3:30 p.m.
but are encouraged to watch the meeting
at www.hhs.gov/live. Should you have
questions during the session, please
email napa@hhs.gov and someone will
respond to your message as quickly as
possible.
To ensure accuracy, please submit a
written copy of oral comments for the
record by emailing napa@hhs.gov by
Wednesday, October 23, 2024. These
comments will be shared on the website
and reflected in the meeting minutes.
In lieu of oral comments, formal
written comments may be submitted for
the record by Wednesday, October 23,
2024, to Helen Lamont, Ph.D., OASPE,
200 Independence Avenue SW, Room
424E, Washington, DC 20201.
Comments may also be sent to napa@
hhs.gov. Those submitting written
comments should identify themselves
and any relevant organizational
affiliations.
FOR FURTHER INFORMATION CONTACT:
Helen Lamont, 202–260–6075,
helen.lamont@hhs.gov. Note: The
meeting will be available to the public
live at www.hhs.gov/live.
SUPPLEMENTARY INFORMATION: Notice of
these meetings is given under the
Federal Advisory Committee Act
(5 U.S.C. App. 2, section 10(a)(1) and
(a)(2)). Topics of the Meeting:
Alzheimer’s disease-related dementias,
clinical care, risk reduction.
Procedure and Agenda: The meeting
will be webcast at www.hhs.gov/live and
video recordings will be added to the
National Alzheimer’s Project Act
website when available after the
meeting. This meeting is open to the
public. Please allow 30 minutes to go
through security and walk to the
meeting room. Participants joining in
person should note that seating may be
limited. Those wishing to attend the
meeting in person must send an email
to napa@hhs.gov and put ‘‘October 21
Meeting Attendance’’ in the subject line
by Wednesday, October 16 so that their
names may be put on a list of expected
attendees and forwarded to the security
officers at the Department of Health and
Human Services. Any interested
member of the public who is a non-U.S.
citizen should include this information
PO 00000
Frm 00124
Fmt 4703
Sfmt 4703
80575
at the time of registration to ensure that
the appropriate security procedure to
gain entry to the building is carried out.
Although the meeting is open to the
public, procedures governing security
and the entrance to Federal buildings
may change without notice. If you wish
to make a public comment, you must
note that within your email.
Authority: 42 U.S.C. 11225; Section
2(e)(3) of the National Alzheimer’s
Project Act. The panel is governed by
provisions of Public Law 92–463, as
amended (5 U.S.C. Appendix 2), which
sets forth standards for the formation
and use of advisory committees.
Dated: September 17, 2024.
Tisamarie B. Sherry,
Deputy Assistant Secretary for Behavioral
Health, Disability, and Aging Policy,
performing the delegable duties of the
Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2024–22763 Filed 10–2–24; 8:45 am]
BILLING CODE 4150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Charter Renewal of the Secretary’s
Advisory Committee on Human
Research Protection
Office for Human Research
Protections, Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services is hereby giving notice
that the charter for the Secretary’s
Advisory Committee on Human
Research Protection (SACHRP) has been
renewed.
FOR FURTHER INFORMATION CONTACT: Ms.
Julia Gorey, Designated Federal Officer
for the SACHRP, Office for Human
Research Protections, 1101 Wootton
Parkway, Rockville, MD 20852. Phone:
(240) 453–8141; Email: SACHRP@
hhs.gov.
SUPPLEMENTARY INFORMATION: SACHRP
is a discretionary Federal advisory
committee. SACHRP is authorized
under 42 U.S.C. 217a, Section 222 of the
Public Health Service (PHS) Act, as
amended. The Committee is governed
by the provisions of the Federal
Advisory Committee Act (FACA), Public
Law 92–463, as amended (5 U.S.C. app),
which sets forth standards for the
formation and use of advisory
committees.
SACHRP functions to provide advice
to the Secretary, through the Assistant
Secretary for Health, on matters
SUMMARY:
E:\FR\FM\03OCN1.SGM
03OCN1
Agencies
[Federal Register Volume 89, Number 192 (Thursday, October 3, 2024)]
[Notices]
[Page 80575]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22763]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Advisory Council on Alzheimer's Research, Care, and Services;
Meeting
AGENCY: Assistant Secretary for Planning and Evaluation, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces the public meeting of the Advisory
Council on Alzheimer's Research, Care, and Services (Advisory Council).
The Advisory Council provides advice on how to prevent or reduce the
burden of Alzheimer's disease and related dementias on people with the
disease and their caregivers. During the meeting, the Advisory Council
will hear updates from federal agencies on activities during the last
quarter and from panels organized by the clinical care and risk
reduction subcommittees. Presenters will discuss dementia care from
different perspectives, including those of providers, people with lived
experience, and CMMI GUIDE Model participants, as well as how to bridge
gaps in service delivery.
DATES: The meeting will be October 21, 2024, from 9:30 a.m. to 4:30
p.m.
ADDRESSES: The meeting will be a hybrid of in-person and virtual. The
meeting will be held in Room 800 of the Hubert H. Humphrey Building,
200 Independence Avenue SW, Washington, DC 20201. It will also stream
live at www.hhs.gov/live.
Comments: Time is allocated on the agenda to hear public comments
from 4:00 p.m. to 4:25 p.m. on Monday, October 21. The time for oral
comments will be limited to two (2) minutes per individual. To provide
a public comment, please register by emailing your name to [email protected]
by Wednesday, October 16. Registered commenters will receive both a
dial-in number and a link to join the meeting virtually; individuals
will have the choice to either join virtually via the link, or to call
in only by using the dial-in number. Note: There may be a 30-45 second
delay in the livestream video presentation of the conference. For this
reason, if you have pre-registered to submit a public comment, it is
important to connect to the meeting by 3:45 p.m. to ensure that you do
not miss your name and allotted time when called. If you miss your name
and allotted time to speak, you may not be able to make your public
comment. Public commenters will not be admitted to the virtual meeting
before 3:30 p.m. but are encouraged to watch the meeting at
www.hhs.gov/live. Should you have questions during the session, please
email [email protected] and someone will respond to your message as quickly
as possible.
To ensure accuracy, please submit a written copy of oral comments
for the record by emailing [email protected] by Wednesday, October 23, 2024.
These comments will be shared on the website and reflected in the
meeting minutes.
In lieu of oral comments, formal written comments may be submitted
for the record by Wednesday, October 23, 2024, to Helen Lamont, Ph.D.,
OASPE, 200 Independence Avenue SW, Room 424E, Washington, DC 20201.
Comments may also be sent to [email protected]. Those submitting written
comments should identify themselves and any relevant organizational
affiliations.
FOR FURTHER INFORMATION CONTACT: Helen Lamont, 202-260-6075,
[email protected]. Note: The meeting will be available to the public
live at www.hhs.gov/live.
SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the
Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and
(a)(2)). Topics of the Meeting: Alzheimer's disease-related dementias,
clinical care, risk reduction.
Procedure and Agenda: The meeting will be webcast at www.hhs.gov/live and video recordings will be added to the National Alzheimer's
Project Act website when available after the meeting. This meeting is
open to the public. Please allow 30 minutes to go through security and
walk to the meeting room. Participants joining in person should note
that seating may be limited. Those wishing to attend the meeting in
person must send an email to [email protected] and put ``October 21 Meeting
Attendance'' in the subject line by Wednesday, October 16 so that their
names may be put on a list of expected attendees and forwarded to the
security officers at the Department of Health and Human Services. Any
interested member of the public who is a non-U.S. citizen should
include this information at the time of registration to ensure that the
appropriate security procedure to gain entry to the building is carried
out. Although the meeting is open to the public, procedures governing
security and the entrance to Federal buildings may change without
notice. If you wish to make a public comment, you must note that within
your email.
Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National
Alzheimer's Project Act. The panel is governed by provisions of Public
Law 92-463, as amended (5 U.S.C. Appendix 2), which sets forth
standards for the formation and use of advisory committees.
Dated: September 17, 2024.
Tisamarie B. Sherry,
Deputy Assistant Secretary for Behavioral Health, Disability, and Aging
Policy, performing the delegable duties of the Assistant Secretary for
Planning and Evaluation.
[FR Doc. 2024-22763 Filed 10-2-24; 8:45 am]
BILLING CODE 4150-05-P